Industry News
You are here: Home » News » Industry News

Latest News & Updates of Loncom Pharma

2026
DATE
07 - 11
NMPA Clarifies Four Priority Review Scenarios for Chemical APIs, Effective August 1, 2026
NMPA's July 2026 announcement specifies four scenarios for chemical API priority review, effective 1 August.
Read More
2026
DATE
07 - 03
ICH Releases E6(R3) Annex 2: Clinical Trial Quality Management Enters the Era of "Decentralised + Real-World Data"
ICH E6(R3) Annex 2 provides GCP guidance for decentralised, pragmatic, and RWD‑enriched trials. It emphasises proportionality, QbD, patient engagement, and early regulator dialogue, reshaping clinical trial quality management for the digital era.
Read More
2025
DATE
08 - 13
The Role of Varenicline Tartrate in Reducing Nicotine Cravings And Withdrawal Symptoms
Quitting smoking is one of the most challenging health decisions many people face. Nicotine addiction is powerful and affects the brain’s reward pathways, making cessation difficult due to intense cravings and withdrawal symptoms. Fortunately, advances in pharmacology have led to the development of medications designed to ease this transition. One such medication that has gained widespread attention and proven efficacy is Varenicline Tartrate.
Read More
2025
DATE
05 - 13
Which Diseases Can Be Treated by Ferrous Fumarate?
Iron is one of the most essential minerals in the human body. It plays a vital role in producing hemoglobin, the molecule in red blood cells responsible for transporting oxygen throughout the body.
Read More
  • Total 4 pages  Go to Page
  • Go
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong, China

QUICK LINKS

PRODUCT CATEGORY

Copyright © 2023 Shandong Loncom Pharmaceutical Co., Ltd. All Rights Reserved. Sitemap | Privacy Policy
Supported by leadong.com
Contact Us